Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Psoriatic arthritis.

D D Gladman1

  • 1University of Toronto, Ontario, Canada.

Current Opinion in Rheumatology
|August 1, 1990
PubMed
Summary
This summary is machine-generated.

Psoriatic arthritis can be severe and disabling, requiring early treatment for better outcomes. Studying HIV infection may reveal new insights into psoriatic arthritis causes and treatments.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Declining levels of serum chemokine (C-X-C motif) ligand 10 over time are associated with new onset of psoriatic arthritis in patients with psoriasis: a new biomarker?

The British journal of dermatology·2020
Same author

Disease course patterns in systemic lupus erythematosus.

Lupus·2018
Same author

Secukinumab provides sustained PASDAS-defined remission in psoriatic arthritis and improves health-related quality of life in patients achieving remission: 2-year results from the phase III FUTURE 2 study.

Arthritis research & therapy·2018
Same author

Severe brady-arrhythmias in systemic lupus erythematosus: prevalence, etiology and associated factors.

Lupus·2018
Same author

Lupus myocarditis: a single center experience and a comparative analysis of observational cohort studies.

Lupus·2018
Same author

Antimalarial-induced cardiomyopathy: a systematic review of the literature.

Lupus·2017
Same journal

New approaches to the management of cutaneous lupus.

Current opinion in rheumatology·2026
Same journal

"Updates in chronic nonbacterial osteomyelitis: emerging insights across the age spectrum".

Current opinion in rheumatology·2026
Same journal

Difficult-to-treat, complex-to-manage, treatment-refractory spondyloarthritis: semantics or substance?

Current opinion in rheumatology·2026
Same journal

Update on IgA nephropathy: implications for treatment in IgA vasculitis: a guide for rheumatologists.

Current opinion in rheumatology·2026
Same journal

Polyarticular juvenile idiopathic arthritis: insights from genetic studies on disease risk and pathogenesis.

Current opinion in rheumatology·2026
Same journal

Immune dysregulation in children with Down syndrome: clinical implications and emerging therapies.

Current opinion in rheumatology·2026
See all related articles

Area of Science:

  • Rheumatology
  • Immunology
  • Infectious Diseases

Background:

  • Psoriatic arthritis (PsA) is a common inflammatory arthritis.
  • A subset of PsA patients experiences severe, disabling disease.
  • Early intervention is crucial for favorable outcomes in PsA.

Purpose of the Study:

  • To explore the unclear pathogenesis of psoriatic arthritis.
  • To investigate how HIV infection as an 'experiment of nature' can elucidate causative mechanisms.
  • To review emerging therapeutic strategies for PsA.

Main Methods:

  • Review of existing literature on psoriatic arthritis and HIV.
  • Analysis of 'natural experiment' cases of HIV-infected individuals with PsA.
  • Synthesis of data on novel treatment modalities.

Related Experiment Videos

Main Results:

  • HIV infection offers a unique model to study PsA pathogenesis.
  • Understanding HIV-associated immune dysregulation may inform PsA mechanisms.
  • Ongoing research into new therapies shows promise.

Conclusions:

  • Further research into HIV and PsA is warranted to clarify pathogenesis.
  • Novel therapeutic approaches are under investigation for psoriatic arthritis.
  • Early and aggressive treatment strategies are essential for severe PsA.